Viewing StudyNCT00171938



Ignite Creation Date: 2024-05-05 @ 11:54 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00171938
Status: TERMINATED
Last Update Posted: 2017-02-24
First Post: 2005-09-13

Brief Title: Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR Platelet Derived Growth Factor Receptors
Sponsor:
Organization: Novartis